Caption Management, LLC Ironwood Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $6.86 Million - $12.7 Million	824,300 Added 659.44%	949,300 $8.27 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $1.1 Million - $1.44 Million	125,000 New	125,000 $1.43 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $45,250 - $61,000	-5,000 Reduced 12.5%	35,000 $398,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $85,800 - $140,100	-10,000 Reduced 20.0%	40,000 $404,000
Q3 2019 Nov 14, 2019	SELL	$8.59 - $10.96 $859,000 - $1.1 Million	-100,000 Reduced 66.67%	50,000 $429,000
Q2 2019 Aug 13, 2019	BUY	$9.8 - $12.89 $319,480 - $420,214	32,600 Added 27.77%	150,000 $1.64 Million
Q1 2019 May 14, 2019	BUY	$8.27 - $12.73 $970,898 - $1.49 Million	117,400 New	117,400 $1.33 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.